Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PTIX

PTIX - Protagenic Therapeutics, Inc. Stock Price, Fair Value and News

$0.490.00 (0.00%)
Market Closed

Price Targets

PTIX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PTIX Price Action

Last 7 days

-10.6%

Last 30 days

-14.3%

Last 90 days

-74.9%

Trailing 12 Months

-91.8%

PTIX RSI Chart

PTIX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PTIX Valuation

Market Cap

887.0K

Price/Earnings (Trailing)

-0.17

Price/Sales (Trailing)

0.02

EV/EBITDA

0.23

Price/Free Cashflow

-0.21

PTIX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

PTIX Fundamentals

PTIX Revenue

Revenue (TTM)

38.6M

PTIX Earnings

Earnings (TTM)

-5.2M

Earnings Growth (Yr)

360%

Earnings Growth (Qtr)

354.26%

PTIX Profitability

EBT Margin

-13.36%

Return on Equity

215.5%

Return on Assets

-116.37%

Free Cashflow Yield

-466.78%

PTIX Investor Care

Shares Dilution (1Y)

298.66%

Diluted EPS (TTM)

-3.45

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20250000
20110038.6M0
20100000
Get all data in R, Python etc through our Historical Stock Data APIs

About Protagenic Therapeutics, Inc.

PTIX
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
0
 WEBSITEprotagenic.com
 SECTORHealthcare
 INDUSTRYBiotechnology

Protagenic Therapeutics, Inc. Frequently Asked Questions

PTIX is the stock ticker symbol of Protagenic Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Mar 12 2026, market cap of Protagenic Therapeutics, Inc. is 887 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu Mar 12 2026, PTIX's PE ratio (Price to Earnings) is -0.17 and Price to Sales (PS) ratio is 0.02. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PTIX PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Protagenic Therapeutics, Inc. has provided -0.42 (multiply by 100 for percentage) rate of return.